Cyclobenzaprine Hydrochloride
Product Images NDC 60760-536

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 60760-536). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

536 (Cyclobenzaprine 60760 536 04)

536 (Cyclobenzaprine 60760 536 04)
Cyclobenzaprine Hydrochloride Tablets, USP 5 mg label showing quantity of 4 tablets. The label includes NDC 60760-536-04, manufactured by Rising Pharma Holdings, Inc., East Brunswick, NJ, and packaged by St Mary's Medical Park Pharmacy, Oro Valley, AZ. It instructs to use as directed, store at controlled room temperature 15°-30°C (59°-86°F), and is marked Rx only.*
FDA Label Image

Chemical Structure (Cyclobenz Str)

Chemical Structure (Cyclobenz Str)
Chemical structure diagram of Cyclobenzaprine Hydrochloride showing its molecular framework with three connected benzene rings and the side chain including a dimethylamino group and hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.